There is controversy regarding the appropriate strategy (anticoagulation vs aspirin) for stroke prevention in low-risk patients (CHA2DS2-VASc score of 0–1). Novel anticoagulants include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback